Pharminicio Expands Its Range with the Acquisition of Decalcit: Moving Towards Comprehensive Nutrition

We are delighted to announce that Pharminicio has successfully acquired Decalcit, a distinguished brand recognized for its calcium and vitamin D₃ supplements. This strategic acquisition is set to enhance our health supplement portfolio, offering our customers comprehensive solutions to support bone health and address calcium and vitamin D deficiencies.

Decalcit, with its proven formulations of calcium phosphate and vitamin D₃, has been at the forefront of addressing various conditions such as osteoporosis, renal osteodystrophy, and hypoparathyroidism. This aligns perfectly with our mission to provide holistic and scientifically-backed health products to our consumers.

By integrating Decalcit's products into Pharminicio's existing range, we are expanding our commitment to improving wellness and preventing nutrient deficiencies across all life stages. We look forward to a new chapter in our journey to enhance the quality of life through superior nutritional support.

For our valued customers and partners, this acquisition means greater access to high-quality supplements and a broader array of options to meet their health needs. As always, we remain dedicated to ensuring the highest standards of product efficacy and safety.

Stay tuned for further updates as we continue to grow and bring the best of health and wellness to your doorstep.